Search in:

Leukemia & Lymphoma Volume 55, 2014 - Issue 2

Submit an article Journal homepage

306

Views

CrossRef citations to date

Altmetric

Research Article

Predictive value of [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant

Wenli QiaoDepartment of Nuclear Medicine

Jinhua ZhaoDepartment of Nuclear MedicineCorrespondence[email protected]

Yan XingDepartment of Nuclear Medicine

Chun WangDepartment of Hematology, The First People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China

Taisong WangDepartment of Nuclear Medicine

Pages 276-282 | Received 28 Sep 2012, Accepted 17 Apr 2013, Published online: 05 Jun 2013

Cite this article
https://doi.org/10.3109/10428194.2013.797974
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Reprints & Permissions

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (19)

Na Dai, Rongcui Cai, Shengming Deng & Shibiao Sang. (2023) Analysis of Positive Results of 18F-FDG PET/CT Imaging after Hematopoietic Stem Cell Transplantation in Lymphoma. Diagnostics 13:12, pages 2027.
Crossref

Belinda A. Campbell, Rachel Brown, Alessandro Lambertini, Michael S. Hofman, Mathias Bressel, John F. Seymour, Andrew Wirth, Michael MacManus & Michael Dickinson. (2023) Are dynamic or fixed FDG‐PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B‐cell lymphoma undergoing autologous haematopoietic stem cell transplantation?. British Journal of Haematology 201:3, pages 502-509.
Crossref

Bernd Metzner, Jutta Welzel, Thomas H. Müller, Jochen Casper, Christoph Kimmich, Eduard K. Petershofen, Andrea Renzelmann, Bernd Rosien, Ruth Thole, Andreas Voss, Kay Willborn & Claus Henning Köhne. (2021) Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual disease. Strahlentherapie und Onkologie 198:1, pages 39-46.
Crossref

N. Sun, W. Qiao, Y. Xing, T. Wang, J. Yang & J. Zhao. (2021) Prognostic value of 18F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation. Clinical and Translational Oncology 23:8, pages 1571-1576.
Crossref

Na Dai, Yeye Zhou, Shengming Deng, Shibiao Sang & Yiwei Wu. (2021) Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores. Contrast Media & Molecular Imaging 2021, pages 1-8.
Crossref

Brandon S. Imber & Joachim Yahalom. (2020) Radiotherapy for Non-Hodgkin Lymphomas. The Cancer Journal 26:3, pages 217-230.
Crossref

Malvi Savani, Mehmet Gencturk, Ryan Shanley, Zuzan Cayci, Christopher Wilke, Erica D. Warlick, Fiona He, Murali Janakiram, Daniel J. Weisdorf, Claudio G. Brunstein & Veronika Bachanova. (2020) Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation 26:2, pages 272-277.
Crossref

Alison K. Yoder, Jillian R. Gunther, Sarah A. Milgrom, Dragan Mirkovic, Loretta Nastoupil, Sattva Neelapu, Michelle Fanale, Nathan Fowler, Jason Westin, Hun Ju Lee, M.Alma Rodriguez, Swaminathan P. Iyer, Luis Fayad, Yago L. Nieto, Chitra Hosing, Sairah Ahmed, L.Jeffrey Medeiros, Joseph D. Khoury, Naveen Garg, Behrang Amini, Bouthaina S. Dabaja & Chelsea C. Pinnix. (2019) Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. Clinical Lymphoma Myeloma and Leukemia 19:1, pages e51-e61.
Crossref

Muhammad Ayaz Mir & Qaiser Bashir. 2019. Hematopoietic Cell Transplantation for Malignant Conditions. Hematopoietic Cell Transplantation for Malignant Conditions 203 208 .

Ghulam Rehman Mohyuddin, Ashley Elizabeth Clark, John Roller, Leyla Shune, Tara Lin, Neil Dunavin, Ajoy Dias, Siddhartha Ganguly, Sunil Abhyankar, Joseph McGuirk & Anurag Singh. (2018) Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience. Hematology/Oncology and Stem Cell Therapy 11:3, pages 135-141.
Crossref

Yun Soo Park, Seok Mo Lee, Ji Sun Park, Sang Kyun Bae, Hye-Kyung Shim, Won-Sik Lee & Sang-Min Lee. (2017) Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation. Nuclear Medicine and Molecular Imaging 52:3, pages 216-223.
Crossref

Andrea K. Ng, Joachim Yahalom, Jayant S. Goda, Louis S. Constine, Chelsea C. Pinnix, Chris R. Kelsey, Bradford Hoppe, Masahiko Oguchi, Chang-Ok Suh, Andrew Wirth, Shunan Qi, Andrew Davies, Craig H. Moskowitz, Siddhartha Laskar, Yexiong Li, Peter M. Mauch, Lena Specht & Timothy Illidge. (2018) Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology*Biology*Physics 100:3, pages 652-669.
Crossref

Hossein Jadvar, Patrick M. Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd J. Krause, Andrei H. Iagaru, Helen Nadel, David I. Quinn, Eric Rohren, Rathan M. Subramaniam, Katherine Zukotynski, Julie Kauffman, Sukhjeet Ahuja & Landis Griffeth. (2017) Appropriate Use Criteria for 18 F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease . Journal of Nuclear Medicine 58:12, pages 2026-2037.
Crossref

Ronald L. Korn, Daniel D. Von Hoff, Mitesh J. Borad, Markus F. Renschler, Desmond McGovern, R. Curtis Bay & Ramesh K. Ramanathan. (2017) 18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer. Cancer Imaging 17:1.
Crossref

P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/CT in the clinical management of patients with lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:5, pages 312-321.
Crossref

P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/TC en el manejo clínico de los linfomas. Revista Española de Medicina Nuclear e Imagen Molecular 36:5, pages 312-321.
Crossref

Hugo J. A. Adams & Thomas C. Kwee. (2017) Pretransplant FDG ‐ PET in aggressive non‐Hodgkin lymphoma: systematic review and meta‐analysis . European Journal of Haematology 98:4, pages 337-347.
Crossref

Chen Wang, Panli Li, Shan Wu, Jianda Lu, Qiufang Liu, Huajie Luo & Shaoli Song. (2016) The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma. Nuclear Medicine Communications 37:4, pages 338-347.
Crossref

Vsevolod Gennad'evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol'tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva & B.V. Afanas'ev. (2016) Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma. Clinical oncohematology 9:4, pages 406-412.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Predictive value of [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant

Articles from other publishers (19)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Predictive value of [18F]fluoro-2-deoxy-d-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant

Citations (19)

Articles from other publishers (19)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Predictive value of [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant